Literature DB >> 12193728

Vitamin K-dependent protein S localizing complement regulator C4b-binding protein to the surface of apoptotic cells.

Joanna H Webb1, Anna M Blom, Björn Dahlbäck.   

Abstract

Apoptosis is characterized by a lack of inflammatory reaction in surrounding tissues, suggesting local control of complement activation. During the initial stage of apoptosis, cells expose negatively charged phospholipid phosphatidylserine on their surfaces. The vitamin K-dependent protein S has a high affinity for this type of phospholipid. In human plasma, 60-70% of protein S circulates in complex with C4b-binding protein (C4BP). The reason why protein S and C4BP form a high-affinity complex in plasma is not known. However, C4BP is an important regulator of the classical pathway of the complement system where it acts as a cofactor in degradation of complement protein C4b. Using Jurkat cells as a model system for apoptosis, we now show protein S to bind to apoptotic cells. We further demonstrate protein S-mediated binding of C4BP to apoptotic cells. Binding of the C4BP-protein S complex to apoptotic cells was calcium-dependent and could be blocked with Abs directed against the phospholipid-binding domain in protein S. Annexin V, which binds to exposed phosphatidylserine on the apoptotic cell surface, could inhibit the binding of protein S. The C4BP that was bound via protein S to the apoptotic cells was able to interact with the complement protein C4b, supporting a physiological role of the C4BP/protein S complex in regulation of complement on the surface of apoptotic cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12193728     DOI: 10.4049/jimmunol.169.5.2580

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  31 in total

Review 1.  Phagocytosis of opsonized apoptotic cells: roles for 'old-fashioned' receptors for antibody and complement.

Authors:  S P Hart; J R Smith; I Dransfield
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

2.  Leishmania disease development depends on the presence of apoptotic promastigotes in the virulent inoculum.

Authors:  Ger van Zandbergen; Annalena Bollinger; Alexander Wenzel; Shaden Kamhawi; Reinhard Voll; Matthias Klinger; Antje Müller; Christoph Hölscher; Martin Herrmann; David Sacks; Werner Solbach; Tamás Laskay
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-31       Impact factor: 11.205

3.  Decreased protein S activity is related to the disease activity of Behcet's disease.

Authors:  Seong Ryul Kwon; Mie Jin Lim; Shin Goo Park; Yeon Sook Moon; Won Park
Journal:  Rheumatol Int       Date:  2006-09-13       Impact factor: 2.631

4.  Annexin A2 and A5 serve as new ligands for C1q on apoptotic cells.

Authors:  Myriam Martin; Jonatan Leffler; Anna M Blom
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

5.  Protein S controls hypoxic/ischemic blood-brain barrier disruption through the TAM receptor Tyro3 and sphingosine 1-phosphate receptor.

Authors:  Donghui Zhu; Yaoming Wang; Itender Singh; Robert D Bell; Rashid Deane; Zhihui Zhong; Abhay Sagare; Ethan A Winkler; Berislav V Zlokovic
Journal:  Blood       Date:  2010-03-26       Impact factor: 22.113

6.  Phosphorylation of protein S by platelet kinases enhances its activated protein C cofactor activity.

Authors:  Fabian Stavenuiter; Andrew J Gale; Mary J Heeb
Journal:  FASEB J       Date:  2013-04-11       Impact factor: 5.191

7.  Vitamin K-dependent proteins in Ciona intestinalis, a basal chordate lacking a blood coagulation cascade.

Authors:  John D Kulman; Jeff E Harris; Noriko Nakazawa; Michio Ogasawara; Masanobu Satake; Earl W Davie
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-16       Impact factor: 11.205

8.  T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response.

Authors:  Eugenio A Carrera Silva; Pamela Y Chan; Leonel Joannas; Andrea E Errasti; Nicola Gagliani; Lidia Bosurgi; Maurice Jabbour; Anthony Perry; Faye Smith-Chakmakova; Daniel Mucida; Hilde Cheroutre; Tal Burstyn-Cohen; Jonathan A Leighton; Greg Lemke; Sourav Ghosh; Carla V Rothlin
Journal:  Immunity       Date:  2013-07-11       Impact factor: 31.745

Review 9.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

10.  Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.

Authors:  Jonatan Leffler; Andrew P Herbert; Eva Norström; Christoph Q Schmidt; Paul N Barlow; Anna M Blom; Myriam Martin
Journal:  J Biol Chem       Date:  2009-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.